Showing results (391-400 of 1,028) with videos related to

Sort By:
Pageof 103
The Lancet. Respiratory Medicine|January 14, 2021
Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort studyRishi K Gupta, Ewen M Harrison, Antonia Ho, et al.
The Lancet. Respiratory Medicine|January 15, 2021
Allocating scarce intensive care resources during the COVID-19 pandemic: practical challenges to theoretical frameworksAlexander Supady, J Randall Curtis, Darryl Abrams, et al.
The Lancet. Respiratory Medicine|October 3, 2019
Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trialLuca Richeldi, Evans R Fernández Pérez, Ulrich Costabel, et al.
The Lancet. Respiratory Medicine|February 13, 2021
Long-term safety and efficacy of tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension studyPatrick A Flume, Reta Fischer Biner, Damian G Downey, et al.
The Lancet. Respiratory Medicine|February 5, 2021
Use of fibrinolytics and deoxyribonuclease in adult patients with pleural empyema: a consensus statementUdit Chaddha, Abhinav Agrawal, David Feller-Kopman, et al.
The Lancet. Respiratory Medicine|October 25, 2016
Added value of combined endobronchial and oesophageal endosonography for mediastinal nodal staging in lung cancer: a systematic review and meta-analysisDaniël A Korevaar, Laurence M Crombag, Jérémie F Cohen, et al.
The Lancet. Respiratory Medicine|November 24, 2016
Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosisSteven D Nathan, Carlo Albera, Williamson Z Bradford, et al.
The Lancet. Respiratory Medicine|October 27, 2018
Paediatric acute respiratory distress syndrome incidence and epidemiology (PARDIE): an international, observational studyRobinder G Khemani, Lincoln Smith, Yolanda M Lopez-Fernandez, et al.
The Lancet. Respiratory Medicine|November 13, 2018
Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trialWilliam W Busse, Eugene R Bleecker, J Mark FitzGerald, et al.
The Lancet. Respiratory Medicine|April 2, 2017
Incidence of severe critical events in paediatric anaesthesia (APRICOT): a prospective multicentre observational study in 261 hospitals in EuropeWalid Habre, Nicola Disma, Katalin Virag, et al.
Pageof 103